Jefferies Lowers Orasure Technologies to Hold

Analyst Ryan Rauch says litigation risk is raised with the likelihood of a lawsuit from Inverness' recent acquisition of Abbott's HIV business

Jefferies sees increased litigation risk for Orasure Technologies (OSUR ), and downgraded the stock to hold from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.